Research Institute: Austin Research Institute
Amount granted: $1.08 million
Year granted: 1991
ACRF has funded the establishment of a research wing for cancer research at the Austin Research Institute. The new wing includes a human cancer research laboratory, a cancer immunotherapy laboratory and an antibody engineering laboratory.
With the assistance of the ACRF grant, researchers at the Institute will work on novel diagnostic tests to aid in the early treatment of colon cancer and in the development of a vaccine for breast cancer.
The Austin Research Institute has patented research advances such as blood tests for the monitoring of breast and ovarian cancer and also pioneered research into ways of overcoming the debilitating effects of chemotherapy.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.